Charles Schwab’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.1M | Buy |
1,614,729
+289,793
| +22% | +$4.86M | ﹤0.01% | 1503 |
|
2025
Q1 | $20.4M | Buy |
1,324,936
+296,012
| +29% | +$4.55M | ﹤0.01% | 1633 |
|
2024
Q4 | $22.7M | Buy |
1,028,924
+129,749
| +14% | +$2.86M | ﹤0.01% | 1631 |
|
2024
Q3 | $16.2M | Buy |
899,175
+177,836
| +25% | +$3.2M | ﹤0.01% | 1811 |
|
2024
Q2 | $11.7M | Buy |
721,339
+26,399
| +4% | +$429K | ﹤0.01% | 1965 |
|
2024
Q1 | $9.81M | Buy |
694,940
+28,294
| +4% | +$399K | ﹤0.01% | 1992 |
|
2023
Q4 | $6.96M | Sell |
666,646
-19,766
| -3% | -$206K | ﹤0.01% | 2170 |
|
2023
Q3 | $7M | Buy |
686,412
+52,436
| +8% | +$535K | ﹤0.01% | 2102 |
|
2023
Q2 | $4.77M | Buy |
633,976
+21,741
| +4% | +$164K | ﹤0.01% | 2249 |
|
2023
Q1 | $5.42M | Sell |
612,235
-7,605
| -1% | -$67.3K | ﹤0.01% | 2164 |
|
2022
Q4 | $5.65M | Sell |
619,840
-7,580
| -1% | -$69.1K | ﹤0.01% | 2153 |
|
2022
Q3 | $5.06M | Buy |
627,420
+23,763
| +4% | +$192K | ﹤0.01% | 2210 |
|
2022
Q2 | $4.54M | Buy |
603,657
+17,686
| +3% | +$133K | ﹤0.01% | 2227 |
|
2022
Q1 | $5.5M | Buy |
585,971
+20,600
| +4% | +$193K | ﹤0.01% | 2225 |
|
2021
Q4 | $4.53M | Buy |
565,371
+17,473
| +3% | +$140K | ﹤0.01% | 2393 |
|
2021
Q3 | $5.34M | Buy |
547,898
+17,101
| +3% | +$167K | ﹤0.01% | 2342 |
|
2021
Q2 | $5.26M | Hold |
530,797
| – | – | ﹤0.01% | 2325 |
|
2021
Q1 | $6.13M | Buy |
530,797
+27,383
| +5% | +$316K | ﹤0.01% | 2193 |
|
2020
Q4 | $4.86M | Buy |
503,414
+13,232
| +3% | +$128K | ﹤0.01% | 2235 |
|
2020
Q3 | $4.42M | Buy |
490,182
+12,358
| +3% | +$111K | ﹤0.01% | 2122 |
|
2020
Q2 | $5.89M | Buy |
477,824
+13,378
| +3% | +$165K | ﹤0.01% | 1946 |
|
2020
Q1 | $4.17M | Buy |
464,446
+42,741
| +10% | +$384K | ﹤0.01% | 1921 |
|
2019
Q4 | $4.13M | Buy |
421,705
+10,735
| +3% | +$105K | ﹤0.01% | 2123 |
|
2019
Q3 | $2.83M | Buy |
410,970
+16,165
| +4% | +$111K | ﹤0.01% | 2253 |
|
2019
Q2 | $3.65M | Buy |
394,805
+53,963
| +16% | +$498K | ﹤0.01% | 2124 |
|
2019
Q1 | $5.35M | Buy |
340,842
+13,135
| +4% | +$206K | ﹤0.01% | 1954 |
|
2018
Q4 | $5.05M | Buy |
327,707
+21,355
| +7% | +$329K | ﹤0.01% | 1895 |
|
2018
Q3 | $6.6M | Buy |
306,352
+9,118
| +3% | +$196K | ﹤0.01% | 1894 |
|
2018
Q2 | $7.23M | Buy |
297,234
+20,714
| +7% | +$504K | 0.01% | 1805 |
|
2018
Q1 | $4.73M | Buy |
276,520
+11,601
| +4% | +$198K | ﹤0.01% | 1973 |
|
2017
Q4 | $5.02M | Buy |
264,919
+17,359
| +7% | +$329K | ﹤0.01% | 1917 |
|
2017
Q3 | $4.36M | Buy |
247,560
+5,989
| +2% | +$105K | ﹤0.01% | 1944 |
|
2017
Q2 | $8.03M | Buy |
241,571
+17,116
| +8% | +$569K | 0.01% | 1503 |
|
2017
Q1 | $7.2M | Hold |
224,455
| – | – | 0.01% | 1542 |
|
2016
Q4 | $8.14M | Buy |
+224,455
| New | +$8.14M | 0.01% | 1411 |
|